Vinpocetine Supplements Market Size, Share & Trends Analysis Report, By Dosage Form (Tablets, Capsules, Powder, and Others), By Application (Dementia, Stroke, Hearing Loss, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce, and Other), By Region, Forecasts, 2024-2031
Vinpocetine Supplements Market Size was valued at USD 268.3 Mn in 2023 and is predicted to reach USD 376.2 Mn by 2031 at a 4.5% CAGR during the forecast period for 2024-2031. The vinpocetine supplements encompass a range of dietary supplements containing vinpocetine, a synthetic compound derived from the periwinkle plant. Vinpocetine is purported to have potential cognitive and neurological benefits, including improving memory, enha...
Report ID: 2515 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Exosome Development and Manufacturing Services Market by Types of Service(s) Offered (Isolated Exosomes, Exosome Characterization, Purification, Chromatography, Engineering, Targeted Delivery, Diagnostic Biomarker, and Quality Control), Scale of Operation (Discovery / Research, Pre-Clinical, Clinical or Commercialized) and By Scalability, Region, and Segment Forecasts, 2024-2031
Exosome Development and Manufacturing Services Market Size is valued at USD 17.2 Bn in 2023 and is predicted to reach USD 62.8 Bn by the year 2031 at an 17.9% CAGR during the forecast period for 2024-2031. Exosomes, which range in diameter from 30 to 150 nm and are membrane-bound extracellular vesicles, are secreted into the extracellular environment by a wide variety of cell types. They develop inside the multivesicular bodies (MVBs) that con...
Report ID: 2514 |
Delivery: Immediate |
Published: June 2024 |
No. of Pages: 180
Therapeutic Proteins and Oral Vaccines Market Size, Share & Trends Analysis Report By Drug Class, By Distribution Channel, By Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, Other Applications), By Region, And By Segment Forecasts, 2024-2031
The Therapeutic Proteins and Oral Vaccines Market Size is valued at 239.91 Million in 2023 and is predicted to reach 436.26 Million by the year 2031 at a 8.1 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The rise in severe diseases such as cancer, diabetes, and autoimmune disorders has increased the demand for therapeutic proteins. These proteins are used for treating conditio...
Report ID: 1037 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Smoking Cessation Market Size, Share & Trends Analysis Report By Products (Smoking Cessation Therapy Products, Drug Therapy, Nicotine Sublingual Tablets, Nicotine Inhalers, E-cigarettes), By End-Users, Region And Segment Forecasts, 2023-2031
The Smoking Cessation Market Size is valued at 25380.0 Million in 2022 and is predicted to reach 53408.9 Million by the year 2031 at a 10.1 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: International frameworks and agreements like the WHO Framework Convention on Tobacco Control (FCTC) drive global efforts to reduce tobacco use as well as promote smoking cessation. Smoking is increasing...
Report ID: 1101 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Hyperpigmentation Disorder Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), By Region, Forecasts, 2024-2031
Hyperpigmentation Disorder Treatment Market Size was valued at USD 6.98 Bn in 2023 and is predicted to reach USD 12.54 Bn by 2031 at a 7.8% CAGR during the forecast period for 2024-2031. Hyperpigmentation disorder treatment issues can be treated with a combination of medical treatments and cosmetic operations that attempt to lessen the appearance and severity of hyperpigmented skin. The rising number of cases of hyperpigmentation disorder trea...
Report ID: 2504 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
rHu Albumin Market Size, Share & Trends Analysis Report By Source (Oryza Sativa, Pichia pastoris, Others), By Application, By End-User (Pharmaceutical and biotechnological industry, Research institutes), By Region, And Segment Forecasts, 2024-2031
The Global rHu Albumin Market Size is valued at 94.88 Million in 2023 and is predicted to reach 218.56 Million by the year 2031 at a 11.16 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The rise in health consciousness among people has increased the demand for albumin in the pharmaceutical production industry, which offers the market opportunities to grow and expand. The increasing awa...
Report ID: 1482 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 178
Polymer Drug Conjugates Market Size, Share & Trends Analysis Report By Product Type (Polymer-Dox Conjugates, Polymer-Paclitaxel Conjugates, Polymer-Camptothecin Conjugates, Polymer-Platinate Conjugates), By Application, By Region, And By Segment Forecasts, 2023-2031
The Polymer Drug Conjugates Market is expected to grow at a 32.0 % CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Growing demand for targeted drug delivery is driving the polymer-drug conjugates market. The increasing incidence of cancer, hepatitis, and other chronic conditions is fueling the need for more effective therapies, boosting the demand for polymer-drug conjugates. North Americ...
Report ID: 1316 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 185
Novel Spectrometry Platforms Market Size, Share & Trends Analysis Report By Type of Spectrometers (Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer, and X-Ray Fluorescence Spectrometer), By End-user, By Region, And By Segment Forecasts, 2023-2031
The Novel Spectrometry Platforms Market Size is valued at USD 13.47 Billion in 2023 and is predicted to reach USD 24.92 Billion by the year 2031 at an 8.4 % CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The increasing complex nature of drug molecules and the need for detailed analysis boost the demand for advanced spectrometry platforms. Rising environmental concerns and regulatory ...
Report ID: 1356 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Lab Workflow Optimization Market Size, Share & Trends Analysis Report, By Type of Solution (Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Laboratory Automation Systems, Scientific Data Management Systems (SDMS), Laboratory Execution Systems (LES), Inventory Management Systems, and Others), By End User (Pharmaceutical and Biotechnology Organizations, Academic and Research Institutes, Contract Research Organizations (CROs), Clinical Diagnostics Laboratories, Food and Beverage Laboratories, Environmental Testing Laboratories, and Others), By Region, Forecasts, 2024-2031
Lab Workflow Optimization Market Size is predicted to develop a 7.1% CAGR during the forecast period for 2024-2031. The primary drivers behind market expansion include the increasing prevalence of laboratory tests and the growing trend of outsourcing laboratory services. As the global population ages and expands, there's a heightened demand for healthcare services, particularly diagnostic testing. Consequently, there's a surge in laboratory te...
Report ID: 2496 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Erectile Dysfunction Drugs Market by Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel, Region And Segment Forecasts, 2024-2031
Erectile Dysfunction Drugs Market Size is valued at USD 2.58 billion in 2023 and is predicted to reach USD 4.60 billion by the year 2031 at a 7.7% CAGR during the forecast period for 2024-2031. Erectile dysfunction refers to the condition where an individual is unable to gain or maintain an erection for a sufficient duration to engage in sexual activity. Sedentary lifestyle-related chronic disorders, including obesity, heart disease, diabetes,...
Report ID: 2483 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Pharmaceuticals